Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARNI in Chronic Heart Failure
NCT03821701Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jun 2018
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sacubitril + valsartan in heart failure with reduced ejection fraction (HFrEF) (4 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Cardiovascular events at 12 months. Status: unknown.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT03821701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03821701.